1,000
Participants
Start Date
October 13, 2021
Primary Completion Date
November 1, 2022
Study Completion Date
November 1, 2026
Non-Interventional Study
First nodule detection CT scans as per eligibility criteria will be used as input into in-house software to extract multiple radiomic features and used to develop a machine learning based classifier to differentiate nodule aetiology. Scans will also be used as input in to a deep learning/convolutional neural network models to perform automated imaging classification.
RECRUITING
The Royal Marsden NHS Foundation Trust (Chelsea Site), London
RECRUITING
Royal Brompton Hospital, London
Institute of Cancer Research, United Kingdom
OTHER
National Institute for Health Research, United Kingdom
OTHER_GOV
Royal Brompton & Harefield NHS Foundation Trust
OTHER
Royal Marsden Partners Cancer Alliance
UNKNOWN
Imperial College London
OTHER
Oxford University Hospitals NHS Trust
OTHER
National Heart and Lung Institute
OTHER
Royal Marsden NHS Foundation Trust
OTHER